Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

ImmunoCellular Therapeutics to expand enrollment in ICT-107 trial

July 4, 2012

Safety results presented on new MedImmune immunotherapeutic

July 4, 2012

Milatuzumab evaluated in elderly patients with chronic lymphocytic leukemia

July 3, 2012

Ono to conduct first-in-human trial of peptide-cocktail cancer vaccine

July 3, 2012

First-in-human data presented on PD-1-targeted cancer immunotherapy

July 2, 2012

Novel potential cancer immunotherapy designed in Korea

June 29, 2012

Bispecific tetravalent cancer immunotherapic is efficacious and safe in vivo

June 27, 2012

First clinical data reported on new whole-cell cancer vaccine

June 26, 2012

Promising data disclosed on novel PD-1/PD-L1-blocking cancer immunotherapies

June 22, 2012

NovaRx completes enrollment in pivotal Lucanix trial

June 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...